Serial Number
79192642
Owner
micromod Partikeltechnologie GmbHAttorney
Martin R. GeisslerFiling Date
Jun 2, 2016
PERIMAG Trademark
Serial Number: 79192642 • Registration: 5258234
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Martin R. Geissler Muncy, Geissler, Olds & Lowe, P.C.
125 S. Royal Street
Alexandria, VA 22314
UNITED STATES
Trademark Details
Filing Date
June 2, 2016
Registration Date
August 8, 2017
Published for Opposition
May 23, 2017
Goods & Services
Chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles composed primarily of magnetizable material for use as contrast agents in Magnetic Resonance Imaging and Magnetic Particle Imaging for use in commercial and scientific applications; nanoparticles and microparticles composed primarily of magnetizable material for use in homing and tracking of stem cells in regenerative medicine and for hyperthermia applications for use in commercial and scientific applications; chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles composed of both magnetizable material and organic polymers for use in biomedical research; chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles that are equipped on their surface with functional properties, namely, antibody-coated, radionuclide doped, and fluorescently labeled for pharmaceutical research, cancer diagnostics and treatment research or stem cell treatment research
[Diagnostic preparations for medical purposes, namely, magnetizeable nano and micro particles for use in carrier-supported immunologice medical test analysis, in biochemistry or clinical chemistry, in transport- and separation-methods for medical testing for the presence of nucleic acids, tumor markers or other disease-relevant biomolecules, and in imaging tests; therapeutic pharmaceuticals, namely, magnetizeable nano and micro particles for the treatment of cancer, auto-immune diseases, or cardiovascular diseases; pharmaceutical and veterinary products, namely, magnetizeable nano and micro particles for use in targeted drug delivery and physical therapy methods, such as magnetic field-induced hyperthermia]
